Subscribe: Market Wire - Medical and Healthcare: Healthcare
Added By: Feedage Forager Feedage Grade B rated
Language: English
announced  care  clinical  company  feb  february  health  marketwired feb  marketwired february  marketwired  medical  new 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Healthcare

Marketwired - Healthcare

Marketwired - Healthcare

Last Build Date: Fri, 17 Feb 2017 16:11:43 EST

Copyright: Copyright: (C) Marketwired

Axiom Real-Time Metrics exhibiting Fusion eClinical Suite at Outsourcing in Clinical Trials -- West Coast in Burlingame, California

Fri, 17 Feb 2017 15:10:02 EST

TORONTO, ON--(Marketwired - February 17, 2017) - Axiom Real-Time Metrics, the premier provider of eClinical software solutions and services to small to mid-sized life sciences organizations, will be exhibiting at the Outsourcing in Clinical Trials event on the West Coast taking place in Burlingame, California on February 22-23, 2017. Axiom invites attendees to join them for gourmet coffee and a conversation at Booth 36.

Kalytera Therapeutics, Inc. Announces Closing of Second Tranche of Brokered Private Placement

Fri, 17 Feb 2017 12:44:26 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 17, 2017) - Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

Addiction Recovery Service Offers Unique Structured Program for Substance Abuse

Fri, 17 Feb 2017 11:20:43 EST

Another Road Addiction Recovery Service, a new Ontario addiction rehabilitation centre for men located just outside Toronto, offers a unique structured recovery program for men seeking help with drug addiction and alcohol abuse

Mesothelioma Expert to Receive Award at Regional Therapies Conference

Fri, 17 Feb 2017 11:00:15 EST

Mesothelioma expert, Mary Hesdorffer, has been selected to receive the Gabriella Graham Patient Advocacy award at the 12th International Regional Therapies conference in Snowbird, UT.

Retired Army Colonel Joe Brown Named Warriors Heart Executive Director

Fri, 17 Feb 2017 11:00:00 EST

Brown Comes Out of Retirement to Help Active/Retired Members of the Military and First Responders Combat Chemical Dependency and Psychological Disorders

First-Ever Heart Valve Disease Awareness Day Puts Condition in the National Spotlight

Fri, 17 Feb 2017 10:00:00 EST

DALLAS, TX--(Marketwired - February 17, 2017) - On February 22, the first-ever National Heart Valve Disease Awareness Day will be celebrated throughout the country. Mended Hearts has joined with other organizations, advocates, and individuals to increase recognition about the risks of heart valve disease (HVD) and improve detection and access to life-saving treatment.

17,000 students to receive CPR and defibrillator training

Fri, 17 Feb 2017 10:00:00 EST

In Celebration of Heart Month

Prolacta Bioscience(R) to Present at the 2017 RBC Capital Markets Healthcare Conference on February 22, 2017

Fri, 17 Feb 2017 09:05:00 EST

DUARTE, CA--(Marketwired - Feb 17, 2017) - Prolacta Bioscience® -- the nation's leading provider of human milk-based neonatal nutritional products, announced today that it will present at the 2017 RBC Capital Markets Healthcare Conference in New York, NY. Scott Elster, Prolacta's President and Chief Executive Officer, is scheduled to present on Wednesday, February 22, 2017 at 11:20 AM EST.

Crown Baus Capital Corp. Acquires 100-Acre Investment Participation in Cannabis Science's California and Nevada Property and Drug Development Projects

Fri, 17 Feb 2017 08:41:57 EST

BEVERLY HILLS, CA--(Marketwired - Feb 17, 2017) - Crown Baus Capital Corp. (OTC PINK: CBCA) announces the Company acquires 100-acre investment participation in the Cannabis Science, Inc. (OTC PINK: CBIS) Property and Drug Development Projects spread across California and Nevada. The agreement includes cultivation, laboratory, and manufacturing capabilities. CBIS will receive 10 million common shares of CBCA as payment in kind. Mr. Dabney is the President, CEO, and Co-Founder of both CBCA and CBIS.

TeraRecon Delivers Virtualization Upgrade with VP CUDA

Fri, 17 Feb 2017 07:00:00 EST

ORLANDO, FL--(Marketwired - February 17, 2017) - TeraRecon (, a leader in advanced visualization and enterprise medical image viewing solutions, releases support for virtualization of their iNtuitionT platform. All new customer systems include the Volume Pro® (VP) CUDA® interface layer as standard, readying the platform for nVidia CUDA® GPUs and eliminating the need for previously required proprietary hardware.

Nerium International Now Open for Business in Hong Kong

Fri, 17 Feb 2017 04:08:35 EST

Leading global relationship marketing company expands its Asia-Pacific presence

Nephros to Present at the SeeThruEquity 3nd Annual Innovations Investor Conference on Feb. 22, 2016

Thu, 16 Feb 2017 18:27:43 EST

RIVER EDGE, NJ--(Marketwired - Feb 16, 2017) - Nephros, Inc. (OTCQB: NEPH) (the "Company"), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD) machine for the treatment of patients with End Stage Renal Disease (ESRD), will present at the SeeThruEquity 3nd Annual Innovations Investor Conference at The W Hotel in Miami on South Beach on February 22, 2017.

Immunotec Reports Record-Breaking Convention Attendance for its "Brand Evolution" Launch

Thu, 16 Feb 2017 16:43:53 EST

VAUDREUIL-DORION, QUEBEC--(Marketwired - Feb. 16, 2017) - Immunotec Inc. (TSX VENTURE:IMM), a direct-to-consumer company and a leader in the nutritional industry (the "Company" or "Immunotec"), launched a comprehensive brand identity update including new packaging for its flagship products, Immunocal® and Immunocal® Platinum, in twin events held in Long Beach, California, and Mexico City at the beginning of February. The two events were attended by almost 4,000 independent Consultants, marking the highest Convention attendance in the Company's history.

Progressive Care Slated to Present at SeeThru Equity Conference in Miami

Thu, 16 Feb 2017 16:19:56 EST

MIAMI, FL--(Marketwired - February 16, 2017) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces that it will be presenting at the SeeThru Equity & Brewer Group 3nd Annual Innovations and Investor Conference on February 22, 2017.

Canadian Centre for Aging and Brain Health Innovation announces up to CAD $2.4 million in funding available to support collaborative innovations in the field of aging and brain health

Thu, 16 Feb 2017 16:11:21 EST

TORONTO, ON--(Marketwired - February 16, 2017) - The Canadian Centre for Aging and Brain Health Innovation (CC-ABHI) announced today the launch of its Researcher-Clinician Partnership Program (RCP2). This program is uniquely designed to greatly enhance the effectiveness of connecting point-of-care clinicians in the senior care sector with university-based researchers to collaboratively design, test and validate innovative products, services or health practices in aging and brain health in a real-world care setting. In total, up to CAD $2.4 million in funding will be available.

MTBC Partners with Pikeville Medical Center

Thu, 16 Feb 2017 15:48:28 EST

'Heart Ball' Fundraiser Supports Heart and Vascular Institute's Continued Service of the Community

Starkey Hearing Technologies' Halo 2 Named 2017 SXSW Interactive Innovation Awards and 2017 Edison Awards Finalist

Thu, 16 Feb 2017 14:52:35 EST

Innovative Made for iPhone(R) hearing technology honored for positive user benefits

Quality Initiative Significantly Improves Outcomes for Children with Chronic Conditions

Thu, 16 Feb 2017 14:35:19 EST

New Study in March 2017 Issue of The Joint Commission Journal on Quality and Patient Safety

Vitamin B3 prevents glaucoma, JAX researchers find

Thu, 16 Feb 2017 14:17:18 EST

BAR HARBOR, ME--(Marketwired - February 16, 2017) - In mice genetically predisposed to glaucoma, vitamin B3 added to drinking water is effective at preventing the disease, a research team led by Jackson Laboratory Professor and Howard Hughes Medical Investigator Simon W.M. John reports in the journal Science.

UPDATE: Tetra Bio-Pharma Reports Approval by Health Canada of its Phase I Trial of PPP001 (dried Cannabis)

Thu, 16 Feb 2017 14:06:57 EST

OTTAWA, ONTARIO--(Marketwired - Feb. 16, 2017) - PhytoPain Pharma Inc. (PPP), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that the Therapeutic Products Directorate (TPD) of Health Canada has approved its Phase I clinical study of smoked cannabis.

Tetra Bio-Pharma Reports Approval by Health Canada of its Phase I Trial of PPP001 (dried Cannabis)

Thu, 16 Feb 2017 12:29:11 EST

OTTAWA, ONTARIO--(Marketwired - Feb. 16, 2017) - PhytoPain Pharma Inc. (PPP), a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain is pleased to announce that the Therapeutic Products Directorate (TPD) of Health Canada has approved its Phase I clinical study of smoked cannabis.

John McKimm Files Early Warning Report

Thu, 16 Feb 2017 12:12:11 EST

MISSISSAUGA, ONTARIO--(Marketwired - Feb. 16, 2017) - John McKimm announces that he has acquired ownership and control over 2,492,200 Common Shares ("Common Shares") of Smart Employee Benefits Inc. ("SEB"), representing approximately 2.0% of SEB's currently issued and outstanding Common Shares. The shares were acquired for $0.20 per share pursuant to a private placement transaction for investment purposes.

drchrono and Physitrack Partner for Patient Engagement Initiative

Thu, 16 Feb 2017 12:05:31 EST

Apple Mobility Partner Program Companies Team Up to Bring Digital Home Exercise Prescriptions and Clinical Exercise Programs to Mobile EHR

Collectes de sang : donneurs recherchés pour compenser les pertes dues au mauvais temps

Thu, 16 Feb 2017 11:34:41 EST

Nous avons un besoin urgent de donneurs de sang pour reconstituer les réserves de sang

Blood donors needed as powerful winter weather disrupts collections across the country

Thu, 16 Feb 2017 11:33:07 EST

Immediate need for donors to give now to replenish blood supplies

Konica Minolta Introduces New Exa Enterprise Imaging Platform at HIMSS 2017

Thu, 16 Feb 2017 10:55:00 EST

Meets Increasing Demand for Interoperability, Data Security

Advanced Clinical Wins Inavero's 2017 Best of Staffing(R) Client and Talent Awards

Thu, 16 Feb 2017 10:03:22 EST

Earned by less than two percent of all staffing agencies in the U.S. and Canada

Equian Achieves HITRUST CSF Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance

Thu, 16 Feb 2017 09:30:00 EST

HITRUST Certification validates Equian is committed to meeting key healthcare regulations and protecting sensitive private healthcare information

Hospital Sisters Health System Contracts with LogicStream Health for Clinical Process Measurement

Thu, 16 Feb 2017 09:30:00 EST

MINNEAPOLIS, MN--(Marketwired - Feb 16, 2017) - LogicStream Health, Inc. announced today that Hospital Sisters Health System (HSHS) has signed an agreement to implement its Clinical Process Measurement solutions. Delivering highly reliable healthcare is HSHS's number one goal in signing the three-year agreement with LogicStream.

Prolacta Bioscience(R) Initiates Clinical Trial to Evaluate the Effect of a Specially Fortified Exclusive Human Milk Diet to Improve Growth in Infants Born with Single Ventricle Congenital Heart Defect

Thu, 16 Feb 2017 09:05:00 EST

DUARTE, CA--(Marketwired - Feb 16, 2017) - Prolacta Bioscience®, the pioneer in human milk-based neonatal nutritional products, announced today that the first patient has been enrolled in a clinical study to evaluate the effect of a specially fortified exclusive human milk diet (EHMD)1 to improve growth in infants who have undergone surgery for a serious heart defect known as single ventricle cardiac physiology. Prolacta developed a first-of-its-kind, human milk-based fortifier to address the post-surgical nutrition needs of this fragile infant population. 

Pegasystems Partners with MuleSoft To Quickly Connect Pega Applications With Third-Party Data

Thu, 16 Feb 2017 09:00:00 EST

MuleSoft's API-based network helps Pega users integrate with third-party apps without coding

Businesses Still Need to Make Affordable Care Act Filings on Time, Says Regulatory Compliance Expert

Thu, 16 Feb 2017 09:00:00 EST

First IRS Deadline for ACA Compliance Filings Only Two Weeks Away

Vitality Biopharma to Present at SeeThruEquity 3rd Annual Innovations Investor Conference in Miami

Thu, 16 Feb 2017 08:55:00 EST

LOS ANGELES, CA--(Marketwired - Feb 16, 2017) - Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, is pleased to advise there will be a corporate presentation at the SeeThruEquity 3rd Annual Innovations Investor Conference to be held on Wednesday, February 22nd at the W Hotel, in South Beach, Miami.

EXOlifestyle, Inc. Provides an Update on Sales and Corporate Activity

Thu, 16 Feb 2017 08:30:00 EST

BOCA RATON, FL--(Marketwired - Feb 16, 2017) - EXOlifestyle Inc. (OTCQB: EXOL), a management firm which develops and operates innovative and healthy brands within the health & wellness industry with a strong focus on athletic gear and apparel, is pleased to provide shareholders 2017 highlights and sales updates.

NHS Scotland Selects NextGate to Assign and Manage the Community Health Index (CHI) Unique Patient Identifier

Thu, 16 Feb 2017 08:00:00 EST

Under Mainframe Solutions Transformation Programme, NextGate EMPI replaces legacy system to modernize management of Electronic Health Record

CTD Holdings Presents Compassionate Use Data on Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C and Provides Update on Progress of U.S. and EU Clinical Trials at 13th Annual WORLDSymposium

Thu, 16 Feb 2017 08:00:00 EST

Company's Phase I U.S. and Phase I/II EU Clinical Trials Expected to Begin Enrolling Initial Patients Shortly

Align Technology Prevails in U.S. Patent Office Proceedings Initiated by ClearCorrect

Thu, 16 Feb 2017 08:00:00 EST

SAN JOSE, CA--(Marketwired - February 16, 2017) - Align Technology, Inc. (NASDAQ: ALGN) today announced that it has prevailed in proceedings initiated by ClearCorrect Operating LLC before the United States Patent and Trademark Office ("USPTO") that challenged the validity of three of Align's U.S. patents.

Jitterbit Announces Growing Momentum for New Healthcare Solutions Including Enhanced Capabilities for Salesforce Health Cloud

Thu, 16 Feb 2017 08:00:00 EST

Jitterbit's Healthcare Interoperability Platform Supports Major Expansion of ASCO's CancerLinQ Ahead of HIMSS17 Health Tech Conference

Eco Science Solutions, Inc. Becomes Presenting Partner Sponsor for Fruit of Life Productions, a Stephen Marley Event

Thu, 16 Feb 2017 07:34:31 EST

MAUI, HI--(Marketwired - Feb 16, 2017) -  Eco Science Solutions, Inc. (OTC PINK: ESSI), an eco-technology Company providing solutions to the multi-billion dollar health, wellness and alternative medicine industry, today announced that it has agreed to become a Presenting Partner Sponsor for Kaya Fest's inaugural event. Kaya Fest is being produced by Stephen Marley, Fruit of Life Productions LLC, and David F. Alfonso. Stephen Marley is an 8-time Grammy Award winner, singer, songwriter, musician, producer and son of legendary music icon, Bob Marley. Kaya Fest brings the Marley brothers together for the first time in more than 20 years. Members of the Marley Family performing are Ziggy, Stephen, Damian, Ky-Mani, including third generation Marleys Jo Mersa, Skip and Shacia Payne. Other musicians include Lauryn Hill, Wyclef Jean, Sean Paul, and Inner Circle, to headline a multi-day education and music event whose goal is to inspire, educate and create positive public awareness of medical marijuana.

Exagen Diagnostics Applauds United Rheumatology's Clinical Practice Guidelines and Recommended Use of Advanced Testing

Thu, 16 Feb 2017 07:20:00 EST

ALBUQUERQUE, NM and SAN DIEGO, CA--(Marketwired - February 16, 2017) - Exagen Diagnostics, Inc., home of AVISE® testing, announced today that United Rheumatology LLC., a leading specialist organization in the United States with over 300 physician members, has prominently recommended testing for methotrexate polyglutimate levels in its clinical practice guidelines for adults with rheumatoid arthritis (RA).

Top US Medical Device Companies Look to 501(k) Clearance to Support Class 2 Devices and PMAs for Class 3 Products

Thu, 16 Feb 2017 07:16:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 16, 2017) - Sixty five percent of surveyed medical device companies report using a 501(k) clearance pathway for Class 2 devices, and 50% trend towards pre-market approvals (PMAs) for regulatory submissions of Class 3 drugs, according to a study by business intelligence firm Cutting Edge Information.

National Rheumatology Group AARA Embraces Exagen Diagnostics' Novel Method to Collect and Test for Widely Used Therapies in Lupus and Rheumatoid Arthritis

Thu, 16 Feb 2017 07:15:00 EST

ALBUQUERQUE, NM and SAN DIEGO, CA--(Marketwired - February 16, 2017) - Exagen Diagnostics, Inc. home of AVISE® testing announced today that AARA powered by Bendcare, a national organization of Rheumatologist in the United States with over 100 physician members, has recommended use of AVISE MTX (methotrexate polyglutamates) and AVISE HCQ (Whole blood Hydroxychloroquine) in routine practice.

Westchester County Dentist Debuts Revamped Website

Thu, 16 Feb 2017 07:01:00 EST

The Center for Cosmetic Dentistry unveils a dynamic new website incorporating innovative features such as intuitive navigation, responsive design, and an interactive testimonial gallery

Medigus Receives Approval for Commencement of the First Multi-Center MUSE Clinical Study from CFDA in China

Thu, 16 Feb 2017 07:00:00 EST

OMER, ISRAEL--(Marketwired - Feb 16, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that the China Food and Drug Administration, or CFDA, has approved the commencement of the first multi-center MUSET Clinical Study in China.

Akers Biosciences Allowed US Patent for Akers Wellness(TM) Tests Cartridge

Thu, 16 Feb 2017 07:00:00 EST

THOROFARE, NJ--(Marketwired - Feb 16, 2017) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces that the United States Patent and Trademark Office has allowed a patent covering Akers Bio's proprietary cartridge for the optical scanning device utilized in the Company's BreathScan LyncT technology. BreathScan LyncT is the new bluetooth-enabled reading device from Akers WellnessT which enables users to track the results of Akers WellnessT breath-based tests via their mobile device.

Reliq Health Technologies Signs Agreement with Paz Home Health, TX, USA to Provide Remote Patient Monitoring to More Than 10,000 Home Care Clients

Thu, 16 Feb 2017 07:00:00 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 16, 2017) - Reliq Health Technologies Inc. (TSX VENTURE:RHT) (OTCQB:RQHTF) ("Reliq" or the "Company"), a technology company focused on creating innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with Paz Home Health LLC in Texas to provide Reliq's hardware and software solutions to their home care clients. Patient enrollment will begin in June 2017 with 500 Paz Home Health patients, building to >10,000 patients and >$6 Million/year in recurring annual revenue in 2018.

Patented Medicine Prices Review Board will hear evidence in the matter of the price of orphan drug Soliris

Wed, 15 Feb 2017 15:30:00 EST

Proceedings to resume February 20, 2017 in Ottawa

Le Conseil d'examen du prix des médicaments brevetés entendra la preuve dans l'affaire du prix du médicament orphelin Soliris

Wed, 15 Feb 2017 15:30:00 EST

La procédure reprendra le 20 février 2017 à Ottawa

Healthwise Appoints New General Counsel

Wed, 15 Feb 2017 15:26:40 EST

Tammy A. Zokan Joins Executive Team

UPDATE - B. Braun Symposium to Focus on Importance of Parenteral Nutrition in Treating Critically Ill Patients

Wed, 15 Feb 2017 13:30:00 EST

BETHLEHEM, PA--(Marketwired - Feb 15, 2017) - The appropriate use of parenteral nutrition, a topic of growing importance for treating critically ill patients, is the focus for the symposium sponsored by B. Braun Medical Inc. at this year's American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Clinical Nutrition Week.

Bitglass Unveils New Integration with Trustwave Managed Security Services

Wed, 15 Feb 2017 13:11:30 EST

New Integration Between Trustwave Managed Detection Service and Bitglass CASB Drives Greater Enterprise Visibility into Cloud-based Threats

Revenues from Polymers for 3D-Printing to Reach $3.2 Billion by 2022

Wed, 15 Feb 2017 12:07:39 EST

CHARLOTTESVILLE, VA--(Marketwired - February 15, 2017) - This new 150-page report "Opportunities in Polymer and Plastic 3D Printing - 2017: An Opportunity Analysis And Ten-Year Forecast" from SmarTech Publishing examines the opportunities in 3D-printed polymers. The study projects this market will reach $3.2 billion by 2022, with 750 million cubic inches of plastic parts being printed.

Ogilvy Healthworld takes home Silver at the 2016 PM Society Awards

Wed, 15 Feb 2017 12:06:04 EST

PARSIPPANY, NJ--(Marketwired - Feb 15, 2017) - Ogilvy CommonHealth Worldwide (, the health behavior change specialists of Ogilvy & Mather (, and a WPP company (NASDAQ: WPPGY) (, today announced its London-based Ogilvy Healthworld agency was awarded a Silver recognition at the PM Society Awards on Friday, February 3rd at the Grosvenor House Hotel in London, UK.

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against USANA Health Sciences, Inc.

Wed, 15 Feb 2017 11:13:45 EST

OKLAHOMA CITY, OK--(Marketwired - Feb 15, 2017) - On February 13, 2017, a class action lawsuit was filed in the United States District Court for the District of Utah against USANA Health Sciences, Inc. (NYSE: USNA). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is March 14, 2014 through February 7, 2017.

Multi-Pronged Product Distribution Agreements Announced by Premier Biomedical Pain Management Solutions for Their Superior Pain Relief Products

Wed, 15 Feb 2017 11:11:32 EST

EL PASO, TX--(Marketwired - Feb 15, 2017) - Premier Biomedical, Inc. (OTCQB: BIEI) announced today their joint venture, Premier Biomedical Pain Management Solutions, LLC (PBPMS), has signed distribution agreement contracts with multi-state pharmacies to sell and distribute PBPMS pain relief products. These outlets augment PBPMS's existing internet sales through their website,, and other direct outlets announced in earlier press releases. Initially, the distribution contracts cover pain relief patches and roll-ons, but will expand as planned new products are introduced later this calendar year.

BAYADA and AlayaCare Partner to Empower Caregivers with Innovative Technology to Simplify Workstreams

Wed, 15 Feb 2017 11:00:00 EST

Partnership will bring on-demand health information, real-time task management, and clinical documentation to the fingertips of home health care clinicians and field employees

PotNetwork's Diamond CBD Scores Over $250,000 in Purchase Orders at the 36th Las Vegas CHAMPS Event

Wed, 15 Feb 2017 10:06:17 EST

Results Exceeded Expectation as Diamond CBD's Robust Product Line was Showcased at the World's Largest and Most Trusted Counter-Culture Trade Show

Irvine Facial Plastic Surgeon Now Offering JUVEDERM VOLBELLA for Lip Enhancement

Wed, 15 Feb 2017 10:01:00 EST

Dr. Ali Sepehr adds JUVEDERM VOLBELLA, a minimally invasive lip enhancement product, to his armamentarium of non-surgical facial enhancement procedures

B. Braun CE Symposium to Focus on Importance of Parenteral Nutrition in Treating Critically Ill Patients

Wed, 15 Feb 2017 10:00:00 EST

BETHLEHEM, PA--(Marketwired - Feb 15, 2017) - The appropriate use of parenteral nutrition, a topic of growing importance for treating critically ill patients, is the focus for the symposium sponsored by B. Braun Medical Inc. at this year's American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Clinical Nutrition Week.

Asterand Bioscience and MolecularMD announce a partnership to accelerate targeted therapeutic biomarker validation, optimization, development and commercialization

Wed, 15 Feb 2017 10:00:00 EST

Partnership facilitates therapeutic biomarker and target validation, assay development and clinical trial management for companion diagnostics and drug development

Hopewell's Lyman House Teaches Independent Living Through Enhanced Transitional Program

Wed, 15 Feb 2017 10:00:00 EST

MESOPOTAMIA, OH--(Marketwired - February 15, 2017) - Hopewell Residential Working Farm offers an enhanced transitional program to persons with mental illness when they are ready to advance to independent living.

MEDIA ALERT: Impinj Hosts Executives from Four of the Country's Leading Healthcare Facilities to Discuss How They're Using IoT to Improve Efficiency and Deliver High Quality Patient Care

Wed, 15 Feb 2017 10:00:00 EST

SEATTLE, WA--(Marketwired - Feb 15, 2017) - HIMSS -- As the healthcare industry grapples with balancing the need for efficiency with high quality patient care, Impinj (NASDAQ: PI), a leading provider and pioneer of RAIN RFID solutions for identifying, locating and authenticating everyday items, has organized a discussion with four of the institutions paving the way with implementation of cutting edge technologies. Coinciding with the 2017 HIMSS Annual Conference, Impinj will host a breakfast panel on Tuesday, Feb. 21 featuring executives from Memorial Sloan Kettering Cancer Center, the Medical University of South Carolina, Inova Fairfax Medical Campus, and the Veterans Administration Salt Lake City.

GrowGeneration Acquires All the Assets of Sonoma Hydro Creating a $2.5 Million Northern California Retail Distribution Center

Wed, 15 Feb 2017 10:00:00 EST

DENVER, CO--(Marketwired - February 15, 2017) - GrowGeneration Corp. (OTCQB: GRWG), GrowGeneration ("GrowGen" or the "Company"), one of the largest specialty retail hydroponic and organic gardening store chains, selling to both the commercial and home cannabis markets, with currently 10 locations in Colorado, 1 location in California and 1 location in Las Vegas, NV, today announced that it has acquired all of the assets of Sonoma Hydro and signed a 5-year lease on a 8,000 square foot facility in Santa Rosa, CA. The Sonoma Hydro location, one of the original hydroponic stores in what is known as the Emerald Triangle, will serve as a retail and warehouse location servicing the growing number of both commercial and home growers in the Northern California market.

Progressive Care Releases Open Letter to Shareholders

Wed, 15 Feb 2017 09:08:17 EST

Open Letter to Shareholders Summarizes Recent Milestones

NASA's "Space Poop" HeroX Challenge Breaks Crowdsourcing Competition Records

Wed, 15 Feb 2017 09:00:00 EST

Three Winners Selected From 5,000 Submissions From 185 Countries to Give Astronauts Better In-suit Waste Management

AlgoSec Joins Splunk Adaptive Response Initiative at RSA 2017

Wed, 15 Feb 2017 09:00:00 EST

AlgoSec and Splunk Combine Forces to Deliver Automated and Continuous Response, Optimize Analytics-Driven Security and Improve Operational Efficiency

Pegasystems Launches Industry's First Robotic Automation Capabilities to Reduce Time and Costs of Managing Onboarding and KYC

Wed, 15 Feb 2017 09:00:00 EST

Pega Robotic Automation now fully unified with Pega CLM and Pega KYC applications

AXIM Biotech Offers the Broadest Pipeline in the Cannabis Industry --

Wed, 15 Feb 2017 09:00:00 EST

REDONDO BEACH, CA--(Marketwired - Feb 15, 2017) -, a leading financial news and information portal offering free real time public company filing alerts, announces the publication of an article discussing AXIM® Biotechnologies Inc.'s (OTCQB: AXIM) recently expanded drug development pipeline.

InMed Pharma CEO Discusses Company's Cannabinoid Biosynthesis -- CFN Media

Wed, 15 Feb 2017 09:00:00 EST

SEATTLE, WA--(Marketwired - Feb 15, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, today announced the publication of an article and video CEO interview covering InMed Pharmaceuticals Inc.'s (OTCQB: IMLFF) (CSE: IN) groundbreaking cannabinoid biosynthesis technology.

Wearable Health Solutions, Inc. (WHSI) Begins Shipping Its Revolutionary iHelp+ 3G Mobile Medical Alert

Wed, 15 Feb 2017 08:45:00 EST

KING OF PRUSSIA, PA--(Marketwired - Feb 15, 2017) -  Wearable Health Solutions, Inc. (OTCQB: WHSI), a Pennsylvania-based wearable health device manufacturer, announces that it is now shipping the much anticipated iHelp+ 3GT mobile medical alert system to dealers in the United States and Canada.

Marijuana Company of America Transitions into Cultivation and Processing With New Agreement

Wed, 15 Feb 2017 08:30:00 EST

BONSALL, CA--(Marketwired - Feb 15, 2017) - MARIJUANA COMPANY OF AMERICA ("MCOA" or the "Company") (OTC: MCOA), an innovative cannabis and hemp marketing and distribution Company, is pleased to announce that it has entered into a non-binding Letter of Intent ("LOI") while performing due diligence to finalize a joint venture agreement with Bougainville Ventures, Inc. ("BV") for the purpose of housing tenant growers engaging in the cultivation, processing and commercial availability of legal marijuana in the State of Washington.

Medovex Corporation Completes Phase II CE Mark Audit with Notified Body LNE/GMED

Wed, 15 Feb 2017 08:30:00 EST

ATLANTA, GA--(Marketwired - Feb 15, 2017) - Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that the Company successfully completed its final CE Mark audit meeting. The review of the Company's DenerveXT System was conducted February 7-9, 2017 by LNE/GMED, a French-based Notified Body firm. This audit is required to demonstrate compliance with the regulatory requirements to achieve CE Mark approval.

Nutra Pharma and Nyloxin Featured on NBC News-Miami

Wed, 15 Feb 2017 08:30:00 EST

Nutra Pharma's over the counter (OTC) products, Nyloxin(R) and Pet Pain-Away(TM), were featured on the NBC News Miami affiliate last night

MedX Health Corp. announces that Dr. Dennis Reich, medical technology devices and software solutions innovator, joins Advisory Board

Wed, 15 Feb 2017 08:23:56 EST

MISSISSAUGA, ON--(Marketwired - February 15, 2017) - MedX Health Corp. ("MedX") (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Dennis Reich to its Medical/Scientific Advisory Board. Dr. Reich is a successful entrepreneur and medical technology advisor as well as a practicing physician. He is President of the Sudbury Primacy Medical Centre, a collaborative medical clinic advancing the utilization of the latest in medical technology, and is a principal investigator in medical trials.

Planning Phase 4 Studies: When (and Where) to Involve Medical Affairs Teams

Wed, 15 Feb 2017 08:08:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 15, 2017) - Global pharmaceutical businesses are the most likely to involve multiple functions in postmarketing, or Phase 4, study planning. A recent study of pharmaceutical companies found that among surveyed global teams, 100% reported involving medical affairs, compliance and legal functions in their Phase 4 strategy-building activities. Additionally, 88% of surveyed global teams involve market access, and 75% involve both marketing and regulatory functions in Phase 4 study plans.

Aspire Ventures Announces Groundbreaking A2I Technology Use in Type 1 Diabetes Study

Wed, 15 Feb 2017 08:00:00 EST

LANCASTER, PA--(Marketwired - Feb 15, 2017) -

Extendicare Announces February 2017 Dividend of C$0.04 per Share

Wed, 15 Feb 2017 08:00:00 EST

MARKHAM, ON--(Marketwired - February 15, 2017) - Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of February 2017, which is payable on March 15, 2017 to shareholders of record at the close of business on February 28, 2017. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).

From Market Compliance to Business Supply: The Necessity for Serialization, New Webinar Hosted by Xtalks

Wed, 15 Feb 2017 07:30:00 EST

TORONTO, ON--(Marketwired - February 15, 2017) - Mario R. Scigliano, Serialization and Automation Manager at CordenPharma Latina S.p.A will address the necessity of serialization from market compliance to business supply, covering all aspects from line choice and regulation approach to management of data and related products. The live event will take place on Wednesday, March 8th, 2017 at 4pm CET (10am EST).

Amedica Granted 180-Day Extension by NASDAQ to Regain Compliance with Minimum Bid Price Rule

Wed, 15 Feb 2017 07:20:00 EST

SALT LAKE CITY, UT--(Marketwired - Feb 15, 2017) - Amedica Corporation (NASDAQ: AMDA), an innovative biomaterial company which develops and manufactures silicon nitride as a platform for biomedical applications, announced today that on February 14, 2017, it received notification from the NASDAQ Stock Market indicating that the Company will have an additional 180-day grace period, until August 14, 2017, to regain compliance with NASDAQ's $1.00 minimum bid requirement. The notification indicated that the Company did not regain compliance during the initial 180-day grace period provided under the rule. In accordance with NASDAQ Marketplace Rule 5810(c)(3)(A), the Company is eligible for the additional grace period because it meets the initial listing requirements for the NASDAQ Capital Market except for the bid price and provided written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

Lisa Ricciardi to Join Board of Directors

Wed, 15 Feb 2017 07:00:00 EST

YONKERS, NY--(Marketwired - February 15, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, announced today that it has appointed Lisa Ricciardi to its Board of Directors. Ms. Ricciardi is a Life Sciences executive with deep business development and operational experience. She has worked for top pharmaceutical, payer, and molecular diagnostics firms including Pfizer, Inc., Medco Health Solutions, Inc., and Foundation Medicine, as well as for Essex Woodlands Health Ventures, a global venture capital partnership. She currently serves on the board of Chimerix, Inc, and United Drug Healthcare Group, PLC, and was a prior board member of Sepracor Inc., which was sold to Dainippon Sumitomo for $2.6 billion.

Providing palliative care makes economic sense

Wed, 15 Feb 2017 06:00:00 EST

VANCOUVER, BC--(Marketwired - February 15, 2017) - Providing palliative care services across Canada would result in better care for less money. Helps American Senior Communities Instantly Assess Quality Metrics of Interest to Post Acute Care Organizations

Wed, 15 Feb 2017 06:00:00 EST

INDIANAPOLIS, IN--(Marketwired - Feb 15, 2017) - The healthcare relationship management (HRM) platform has been adopted by American Senior Communities (ASC), one of the nation's largest providers of senior living, rehabilitation, hospice, and skilled nursing services, with 87 locations in Indiana.

Swisslog Healthcare Launches Strategic Partnership in South Korea

Tue, 14 Feb 2017 20:00:00 EST

Committed to serving the Korean healthcare sector, Swisslog Korea Co., Ltd was incorporated and has successfuly integrated with Telecar, the Swisslog distributor in Korea. Swisslog Korea has earned its first significant customer order from EWHA Womans University Medical Center

MYOS RENS Technology Inc. Adopts Shareholder Rights Plan

Tue, 14 Feb 2017 18:00:00 EST

CEDAR KNOLLS, NJ--(Marketwired - Feb 14, 2017) - MYOS RENS Technology Inc. (the "Company") (NASDAQ: MYOS) today announced that its Board of Directors ("Board") has adopted a shareholder rights plan (the "Rights Plan").

Vigil Reports Record Earnings and Revenue in Third Quarter

Tue, 14 Feb 2017 16:53:28 EST

VICTORIA, BC--(Marketwired - February 14, 2017) - Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE: VGL) announces the results of operations for the quarter ending December 31, 2016.

PharmaCan Capital Announces $15 Million Bought Deal

Tue, 14 Feb 2017 16:24:09 EST

TORONTO, ONTARIO--(Marketwired - Feb. 14, 2017) -

B. Braun Medical to Present Comprehensive Parenteral Nutrition Program at ASPEN's Clinical Nutrition Week

Tue, 14 Feb 2017 15:40:00 EST

BETHLEHEM, PA--(Marketwired - Feb 14, 2017) -  B. Braun Medical Inc., a leader in customized parenteral nutrition, will present its new parenteral nutrition program -- PN360 -- designed to improve neonatal, pediatric and adult patient outcomes -- at this year's American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Clinical Nutrition Week.

Civitas Capital Group promotes from within its accomplished investor relations team; hires additional new talent

Tue, 14 Feb 2017 12:39:32 EST

The Civitas investor relations team has helped thousands of investors and institutions from more than 30 countries around the world invest capital in the United States

Quad Cities Orthopaedic Surgeon Discusses Past, Present, and Future of Hand Surgery

Tue, 14 Feb 2017 12:33:52 EST

Dr. Tyson Cobb of Orthopaedic Specialists, PC recently presented his research and experience performing minimally invasive treatment of CMC Arthritis at the combined conference for IFSHT and IFSSH

JobDiva Introduces Team Dashboard for Company-Wide Performance Metrics

Tue, 14 Feb 2017 11:38:30 EST

NEW YORK, NY--(Marketwired - February 14, 2017) - Today JobDiva, the leading global Applicant Tracking System and Talent Management solution, brings amplified visibility to company-wide performance metrics. JobDiva has leveraged its peerless understanding of the recruitment business to create a dynamic Team Dashboard. The JobDiva Team Dashboard offers granular data about all of your company's activities, within a historical context.

M*Modal Awarded #1 KLAS Category Leader for Speech Recognition, Back-End in Annual Report

Tue, 14 Feb 2017 11:10:00 EST

M*Modal Fluency for Transcription achieves the top ranking from leading healthcare organizations for helping clients deliver better patient care

Invivoscribe anuncia Acuerdo de Colaboración a largo plazo con Illumina y planea lanzamiento de kits de ensayo IVD basados en NGS

Tue, 14 Feb 2017 11:01:56 EST

SAN JOSÉ, CA--(Marketwired - Feb 14, 2017) - Invivoscribe(R) Technologies Inc., una compañía internacional con décadas de experiencia ofreciendo soluciones de pruebas de clonalidad y biomarcador para los campos de oncología y diagnóstico molecular personalizado (R) y medicina molecular personalizada (R), anuncia hoy su acuerdo de colaboración a largo plazo con Illumina(R) Inc., para el desarrollo y comercialización de ensayos de diagnóstico in vitro (IVD) para la plataforma de secuenciación de próxima generación (NGS) MiSeqDx(R). Este acuerdo permite a Invivoscribe traer ensayos de IVD a través de la FDA, conjuntamente con el software de bioinformática asociado, para venta y distribución en Estados Unidos.

Regence, Utah Physician Groups Report Impressive Results from New Care Management Model

Tue, 14 Feb 2017 11:00:00 EST

Results from six Utah physician groups show Regence's Total Cost of Care program, by sharing more information and analytic tools, enables physicians to make better patient care decisions

Changing consumer landscape drives demand for machine-learning and AI-powered search

Tue, 14 Feb 2017 10:59:48 EST

CY 2016 was a year of tremendous growth, innovation, and recognition as revenues soar 80% for intelligent search leader

Phase 2 Carb Controller Makes for a More Indulgent Valentine's Day

Tue, 14 Feb 2017 10:49:39 EST

KEARNY, NJ--(Marketwired - Feb 14, 2017) - Valentine's Day is a time to show the ones you love how much you care, which is often expressed with elaborate five-course dinners and decadent desserts and treats. And while most Valentine's Day feasts can leave you in a carb coma, feeling bloated and over-stuffed, this not-so-romantic situation can be averted by first consuming a specific white kidney bean extract called Phase 2 Carb Controller that has been clinically shown to block, on average, 65 percent or more of unwanted carbohydrates from absorbing into the body according to a study published in Nutrition Business Journal

LogicStream Health Deploys v6.0 of Clinical Process Measurement Platform

Tue, 14 Feb 2017 10:37:58 EST

MINNEAPOLIS, MN--(Marketwired - Feb 14, 2017) - LogicStream Health, Inc. announced today that version 6.0 of its Clinical Process Measurement platform has been deployed into production at all its client sites. The latest release from the company, which delivers better processes and better outcomes, solidifies the Clinical Process Measurement framework previously available. All the functionality of the solution will be on display at Booth 875 during the HIMSS 17 conference in Orlando, Fla., February 19 to 23, 2017.

Amazonas Florestal Ltd. Today Announced that Its Wholly Owned Subsidiary Amazon Hemp Ltd. Has Executed a Farm Contractor Agreement with 303 Farms LLC to Establish 100 Acre CBD Hemp Plantation in the State of Colorado

Tue, 14 Feb 2017 10:28:33 EST

MIAMI, FL--(Marketwired - Feb 14, 2017) - Amazonas Florestal, Ltd. ( (OTC PINK: AZFL), a natural resources company dedicated to innovative, sustainable forest management, the certification and sales of carbon credits, and Industrial CBD Hemp, today announced that the company's wholly-owned subsidiary Amazon Hemp Ltd. has completed and signed a Farm Contractor Agreement with 303 Farms LLC covering all of the required elements to establish a 100-acre Industrial CBD Hemp Plantation in Frederick, Colorado, just north of Dacono, Colorado.

SHOM Gains 11 AAA Cooperative Hospitals with Medical Treasure to Increase Its Reach Into the Global Healthcare Market

Tue, 14 Feb 2017 10:28:19 EST

NEW YORK, NY--(Marketwired - Feb 14, 2017) - Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer in the Healthcare industry, has gained 11 AAA Cooperative hospitals in the contract signing with Medical Treasure as part of a mutually beneficial collaboration.

swyMed Introduces the DOT Telemedicine Backpack, Enabling Connectivity for Real-Time Mobile Video Consultations from Any Location

Tue, 14 Feb 2017 10:00:00 EST

First-of-its-kind, plug-and-play backpack reliably connects patients and doctors to improve care and reduce costs

CloudMedx Releases New Risk Adjustment Module for Large Healthcare Providers and Physician Groups

Tue, 14 Feb 2017 10:00:00 EST

PALO ALTO, CA--(Marketwired - Feb 14, 2017) - CloudMedx, a Health AI analytics company, today announced its release of risk adjustment module as part of its Clinical AI Platform. For larger healthcare providers, physician practices, and systems they will now be able to leverage their unstructured data to automate their risk adjustments for high risk patients. For payers, they can now get highly accurate risk scores to assess the overall health of their risk pool, ensure that they are reimbursed appropriately by the Centers for Medicare & Medicaid Services (CMS) based on how sick their members actually are, and know whether they will receive transfer payments or pay them out.